期刊
THROMBOSIS RESEARCH
卷 218, 期 -, 页码 8-16出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.thromres.2022.08.003
关键词
Splanchnic vein; Thrombosis; Myeloproliferative; Polycythemia vera; Essential thrombocythemia; Myelofibrosis
资金
- American Cancer Society [129819-IRG-16-189-58-IRG-114]
- American Heart Association Career Development Award [OT2 HL15275801]
This review summarizes the epidemiology, pathogenic features, and clinical management of myeloproliferative neoplasm (MPN) with splanchnic vein thrombosis (SVT), highlighting the central role of endothelial cells in this condition.
Splanchnic vein thrombosis (SVT) in the setting of myeloproliferative neoplasm (MPN) is a unique clinical entity that requires close interdisciplinary coordination for proper diagnosis and management. The pathobiology of MPN-SVT is not fully understood, but recent developments have revealed the central role of endothelial cells. In this multidisciplinary review, we summarize the epidemiology of MPN-SVT and then critically evaluate the pathogenic features of this complication, with a focus on endothelial cell biology. We then discuss diagnostic considerations, including imaging modalities and MPN-specific investigations. Finally, we critically review the evidence supporting clinical management of MPN-SVT, including anticoagulation, interventional radiology procedures, MPN-related therapies, and liver transplantation. We conclude that further studies are needed to improve our understanding of MPN-SVT and the outcomes of patients with this debilitating complication.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据